Cargando…
A National Representative, Cross-Sectional Study by the Hellenic Academy of NeuroImmunology (HEL.A.NI.) on COVID-19 and Multiple Sclerosis: Overall Impact and Willingness Toward Vaccination
Background: In the context of the coronavirus disease 2019 (COVID-19) pandemic, the constant needs of people with multiple sclerosis (PwMS) and their caregivers were urgently highlighted. Aim: The present study aims to capture the effects of the COVID-19 pandemic in several aspects of the quality of...
Autores principales: | Boziki, Marina, Styliadis, Charis, Bakirtzis, Christos, Grigoriadou, Eleni, Sintila, Aggeliki-Styliani, Nikolaidis, Ioannis, Vrienniou, Aliki, Geys, Lotte, Pelidou, Sygkliti-Henrietta, Probert, Lesley, Papazisis, Georgios, Bamidis, Panagiotis, Grigoriadis, Nikolaos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656423/ https://www.ncbi.nlm.nih.gov/pubmed/34899577 http://dx.doi.org/10.3389/fneur.2021.757038 |
Ejemplares similares
-
The Role of Diet and Interventions on Multiple Sclerosis: A Review
por: Stoiloudis, Panagiotis, et al.
Publicado: (2022) -
Biomarkers in Rare Demyelinating Disease of the Central Nervous System
por: Boziki, Marina, et al.
Publicado: (2020) -
Long-Term Efficacy Outcomes of Natalizumab vs. Fingolimod in Patients With Highly Active Relapsing-Remitting Multiple Sclerosis: Real-World Data From a Multiple Sclerosis Reference Center
por: Boziki, Marina, et al.
Publicado: (2021) -
Blood Metabolomics May Discriminate a Sub-Group of Patients with First Demyelinating Episode in the Context of RRMS with Increased Disability and MRI Characteristics Indicative of Poor Prognosis
por: Boziki, Marina, et al.
Publicado: (2022) -
Ocrelizumab in Patients with Active Primary Progressive Multiple Sclerosis: Clinical Outcomes and Immune Markers of Treatment Response
por: Boziki, Marina, et al.
Publicado: (2022)